This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (6)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Dermatology  • Immunology  • Alert me on articles by topic

Our Experience

Arch Otolaryngol Head Neck Surg. 1998;124:1179-1180.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

AS CAN BE seen from Ferguson's review of the literature and treatment options, AFRS remains an enigma to us 17 years after it was described. What we have learned raises many more questions than we have answers.

Figure appears in full text version. Frederick A. Kuhn, MD

To address some of the issues raised in her review, we believe that IT may prove to be the next advance in our treatment regimen for AFRS; however, some of the problems with IT include the following: (1) the exact fungus causing the patient's problem must be identified; (2) antigens are not available for all fungi, necessitating the use of similar fungal antigens; (3) IT appears to only control, not eliminate, the disease in some patients; and (4) we do not know whether the disease will recur after IT is finished.

Figure appears in full text version. Amin R. Javer, MD

Our experience with oral antifungals is mixed. Two patients exemplify the results. The first, . . . [Full Text of this Article]

RELATED ARTICLES

What Role Do Systemic Corticosteroids, Immunotherapy, and Antifungal Drugs Play in the Therapy of Allergic Fungal Rhinosinusitis?
Berrylin J. Ferguson
Arch Otolaryngol Head Neck Surg. 1998;124(10):1174-1178.
EXTRACT | FULL TEXT  

Allergic Fungal Rhinosinusitis: Experience With Immunotherapy
Richard L. Mabry and Cynthia S. Mabry
Arch Otolaryngol Head Neck Surg. 1998;124(10):1178-1179.
EXTRACT | FULL TEXT